FIND’s Executive Director Roosevelt WoodsThe Foundation for International Dignity (FIND), with support from the Government of Japan through the United Nations Development Program (UNDP), has started a new project in Nimba County.“FIND will conduct situational analyses of the socioeconomic and cultural status, as well as local economic development opportunities and challenges, in Nimba County. It will make recommendations on how the local economies can be stimulated for growth and development,” according to a press release signed by FIND’s Executive Director, Roosevelt A.K. Woods.FIND is a pro-democracy and human rights organization working to promote peace, good governance, the rule of law and access to justice in Liberia.Woods said a series of focus group discussions, awareness activities and training in peace building as well as conflict prevention mechanisms will also take place.The project, which is titled: ‘Supporting and Strengthening Sub-regional Post-Ebola Medical Surveillance and Socio-Economic Recovery Initiatives in West Africa,’ is designed to provide technical assistance and support at sub-regional, national and grassroots level to the three Ebola affected countries (Liberia, Sierra Leone and Guinea), and Côte d’Ivoire.The project will also assist the countries to address urgent needs in health, social and economic recovery, and conflict prevention and peace building in common border areas.“In addition, the project will strengthen coherence and coordination between the UNDP Country Offices on cross-border recovery and resilience initiatives in order to assist border communities to better respond to disasters,” said Woods.“Under the initiative, FIND will work alongside six strategic border towns in Nimba County, including Dubuzon, Buutuo, Gborplay, Luguato, Kissiplay and Duoplay,” he added.FIND was established in 2002 to respond to the growing human rights concerns of Liberian refugees. In response to the Liberian government’s decentralization call, FIND constructed its new headquarters in Gbarnga, Bong County in June 2011 and subsequently moved there from Monrovia in December the same year.Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
Since HHS announced in late September a wide-ranging audit of the use of fetal tissue in federally funded research, groups that have long sought to outlaw its use say they are finally being heard. They view such research as morally repugnant and unnecessary because they contend other techniques can be used — an assertion many scientists reject. “This is a pro-life administration,” said David Prentice, vice president and research director of the antiabortion Charlotte Lozier Institute, who said members of his group and the affiliated Susan B. Anthony List have met with Pence to press their case. “It’s just nice to have someone who will listen and not just close the door in your face.” (Bernstein, Goldstein and Sun, 12/12) Stat: Freeze On Fetal Tissue Procurement May Impede Work At NIH Cancer Lab The New York Times: Fetal Tissue Research Is Curtailed By Trump Administration The National Institutes of Health freeze on fetal tissue procurement is threatening to hamper work at an agency lab conducting cancer research, the latest sign that a Trump administration decision could slow the efforts of some scientists who depend on the samples. …The spokeswoman, Renate Myles, declined to identify the lab for “security reasons,” but said that the group is working on cancer immunotherapy.Two other NIH labs, one in Montana and another at the National Eye Institute, are also conducting research using fetal tissue that could ultimately be affected by the suspension. (Swetlitz, 12/12) The Washington Post: Fetal Tissue Research Targeted By Abortion Foes Inside Administration Quietly Simmering Feud Over Fetal Tissue Research Is Reaching Its Boiling Point The Trump administration back in September launched an audit over all government-funded fetal tissue research, citing “serious regulatory, moral, and ethical considerations.” The decision recently affected a lab that has played a key role in testing antiviral drugs to treat HIV infection, highlighting the far-reaching ramifications of the debate. Should the government pay for medical research that uses tissue from aborted fetuses? This debate, ever smoldering, has erupted again, pitting anti-abortion forces in the Trump administration against scientists who say the tissue is essential for studies that benefit millions of patients. In a letter last week that read like a shot across the bow, the National Institutes of Health warned the University California, San Francisco, that its $2 million contract for research involving the tissue, previously renewed for a year at a time, would be extended for only 90 days and might then be canceled. (Grady, 12/12) This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.